Medical Feed Additives Global Market Report 2024

The medical feed additives market size has grown strongly in recent years. It will grow from $15.9 billion in 2023 to $17.28 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed during the historic period can be ascribed to several factors such as the enhancement of livestock health and productivity, disease prevention, the usage of nutritional supplements, and the subsequent increase in meat and dairy production.

The medical feed additives market size is expected to see strong growth in the next few years. It will grow to $23.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The projected growth in the upcoming period is expected to be influenced by various factors, notably sustainable animal agriculture, the development of antibiotic alternatives, precision livestock farming, and an increased focus on nutrition and animal health. Noteworthy trends expected in this period encompass sustainability and animal welfare, precision nutrition, the rise of alternative protein sources, and an increased emphasis on education and training within the industry.

The medicated feed additives market is experiencing growth due to an increase in the prevalence of diseases among animals. As of July 2023, the World Health Organization reported that the World Organization for Animal Health received information about H5N1 high pathogenicity avian influenza outbreaks in livestock and wild birds, spanning 67 countries on five continents. This resulted in the loss of approximately 131 million domestic fowl in 2022. The use of additives in animal feed not only helps prevent diseases but also enhances the nutritional value of the feed, driving higher demand for these feed additives.

The additives primarily encompass antioxidants, antibiotics, probiotics, prebiotics, enzymes, and amino acids. Antioxidants encompass a spectrum of nutritional feed additives administered to animals. These products come in various forms, including supplements, concentrates, premixed feeds, and base mixes. These products are available in diverse classes such as typing a, type b, and type c, catering to varied livestock including ruminants, poultry, swine, and aquaculture.

The medical feed additives market research report is one of a series of new reports that provides medical feed additives market statistics, including medical feed additives industry global market size, regional shares, competitors with medical feed additives market share, detailed medical feed additives market segments, medical feed additives market trends and opportunities, and any further data you may need to thrive in the medical feed additives industry. This medical feed additives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth of the medicated feed additives market is expected to be fueled by the increasing size of livestock farms. These farms, which raise animals like cattle, sheep, pigs, chickens, and other livestock for various purposes such as meat production, egg production, and dairy products, are expanding in scale. This expansion has created a need for feed additives that can boost feed efficiency and promote animal health. Factors contributing to this trend include rising demand for livestock-based products, the necessity for improved feed efficiency, increased attention to animal well-being, stringent quality regulations for meat production, the commercialization of livestock farming, and geographical expansion. For example, as of February 2022, the National Agricultural Statistics Service reported that the average farm size in the United States increased slightly from 444 acres in the previous year to 445 acres in 2021, with larger growth in the sales class exceeding $1,000,000.

The overuse and inappropriate use of antibiotics in medicated feed additives have significant implications for both human and animal health. As of April 2023, the United States Food and Drug Administration took action to address this issue by banning certain off-label applications of cephalosporin antimicrobial medicines in animals intended for food production. This decision was driven by concerns over antibiotic overuse and misuse in food-producing animals, which led to the selective evolution of antimicrobial-resistant bacteria, increasing the risk of infections in humans. Excessive use of feed additives in animals not only affects human health by exposing consumers to potential risks from antibiotic residues in animal products but also harms the animals themselves. The overuse of antibiotics weakens animals' natural immunity and makes them more susceptible to infections, negatively impacting their health. These issues pose constraints on the growth of the medicated feed additives market.

The medical feed additives market is witnessing a trend where companies are introducing new products that are the result of combining two or more medicated feed additives. Over 70% of manufacturers are embracing this approach to boost the efficiency of their products. For example, Zoetis, a global health company, received FDA approval for its combination feed additive of Cyden and Lincomix, specifically designed for poultry. Another FDA-approved combination involves Zoetis' ACTOGAIN 45 and ENGINE additives, which aim to increase lean muscle and reduce fat while improving feed efficiency.

Key companies in the medical feed additives market are prioritizing innovation by developing products like Biolys, a specialized livestock feed formulation, to better cater to their consumer needs. Livestock feed formulation involves creating a nutritious diet for animals by combining various nutrients in appropriate proportions to meet their nutritional requirements. For instance, in June 2023, Evonik Industries AG, a Germany-based chemical firm, launched an enhanced version of Biolys, a significant lysine source for animal feed. This updated formulation contains a higher concentration of L-lysine and incorporates valuable fermentation residues to provide additional energy and minerals, benefiting animals such as pigs or chickens. The new Biolys allows customers to more efficiently meet their animals' critical amino acid L-lysine needs.

Companies within the medical feed additives market are strategically acquiring firms to bolster their expertise and expand their market presence. In June 2022, Cargill, Inc., a US-based food and agriculture company, acquired DelaconBiotechnik GmbH, an Austria-based pioneer in phytogenic feed additives, for an undisclosed sum. This acquisition merges Delacon's innovative expertise in plant-based phytogenic additives with Cargill's extensive global network and deep knowledge in animal nutrition technologies. Phytogenic feed additives, utilizing herbs, plants, and their extracts, including essential oils, aim to enhance livestock and aquaculture performance, improve animal health, and bolster Cargill's research capabilities in feed additives.

Major companies operating in the medical feed additives market include Zoetis Inc., Cargill Incorporated, CHS Inc., Purina Animal Nutrition LLC, Archer Daniels Midland Company, Adisseo France Sas, Alltech Inc., Hipro Animal Nutrtion, BASF SE, Biostadt India Limited, Zagro Co. Ltd., Koninklijke DSM NV, Novozymes AS, Nutreco N.V., Phillip Brothers Chemicals Inc., Evonik Industries AG, Diamond V, neovia logistics holdings Ltd., Delacon Biotech Nik GmbH, Abaxis Inc., Wen's Food Group, Muyuan Foodstuff, BRF Brasil Foods, Tyson Foods, ForFarmers N.V, Kemin Industries, DuPont de Nemours Inc., Solvay SA, Ajinomoto Co. Inc., Chr. Hansen A/S, Red Nucleus, HI-PRO Feeds, Novus International Inc., Provimi Holding B.V., Lallemand Inc., Pancosma S.A., Trouw Nutrition International B.V., Anpario plc, Biovet JSC, BioResource International Inc.

North America was the largest region in the medical feed additives market in 2023. Asia-Pacific was the second-largest region in the medical feed additives market. The regions covered in the medical feed additives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical feed additives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The medical feed additives market consists of sales of digestibility enhancers, coccidiostats and histomonostats, antimicrobials, and growth hormones. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.